Skip to main content

News

Systemic Steroids Seldom Flare Psoriasis

A tenet of drug management suggests that steroid use in psoriasis may be associated with rebound flares; well this has been challenged by a new observational trial showing that the risk of flares (and severe flares) of psoriasis flares were seldom triggered by systemic steroids - certainly much l

Upadacitinib Effective in Biologic Refractory Psoriatic Arthritis

The SELECT-PsA 2 trial was presented at the ACR meeting and recently published in Annals of Rheumatic Disease, shows that psoriatic arthritis (PsA) patients who have failed at least one biologic DMARD, did respond well to upadacitinib.

Medicare Physician Fee Schedule Final Rule Released

Centers for Medicare & Medicaid's CY 2021 Medicare Physician Fee Schedule final rule provides much-needed increases in Medicare reimbursement for the evaluation and management (E/M) services provided by rheumatologists and other cognitive care specialties to Medicare beneficiaries.

Mortality in Low Dose Prednisone

Upon release of the new ACR 2020 Pharmacologic Treatment Recommendations for the Management of Rheumatoid Arthritis, many practitioners were surprised that the new guidelines recommended against glucocorticoid initiation at disease onset.

ACIP Recommendations for Pfizer Vaccine Candidate

The CDC advisory panel, ACIP, has voted and declared that the first wave of vaccines should go to the front line healthcare workers and elderly residents in long term care facilities as part of Phase1a. The decision was not unanimous.

RheumNow Podcast – Back Talk Listener Questions (12.04.20)

Dr Jack Cush takes questions from RheumNow listeners

PIANO Study - Safety of Biologics in Pregnancy

The results of the long awaited PIANO study have been reported in the journal Gastroenterology, showing that pregnant women with IBD may safely receive biologic or thiopurine therapy throughout the pregnancy without substantial added risk to the unborn or mother.

Colchicine Approval Took a Huge Toll on CMS

MedPage Today

Colchicine, the old gout drug often cited as a cheap anti-inflammatory, hasn't been such a good deal since FDA approval, a study in JAMA Internal Medicine showed.

How are RA patients doing using telemedicine/virtual care?

Rheumatologists switched their practices overnight from primarily in person to nearly all virtual care as COVID-19 pandemic geared up in March 2020 and then to a blend of in person and virtual care. How are RA patients doing?

Racial disparities in Bilateral Knee Arthroplasty in Osteoarthritis

Although arthritis-related activity, disabling work limitations, and severe pain (which are indications for TKA) disproportionately impact African American patients compared to White patients, there are marked racial disparities documented in utilization and complications in unilateral total knee arthroplasty.  

Measuring Disease Activity in PsA: Dr. Eric Ruderman

In this video, Dr. Eric Ruderman looks at abstracts #0884, #0323 and #0909, which focus on disease activity measurement in psoriatic arthritis, presented at the 2020 ACR Convergence meeting earlier this month. 

The tantalising prospect of glucocorticoid-free treatments for systemic vasculitis

Glucocorticoids are a highly effective treatment in systemic vasculitis but are also a significant cause of long-term harm in the form of treatment related adverse events.

×